Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M004070200 on July 24, 2000

J. Biol. Chem., Vol. 275, Issue 40, 31514-31519, October 6, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/40/31514    most recent
M004070200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKenzie, M.
Right arrow Articles by Trounce, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKenzie, M.
Right arrow Articles by Trounce, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Expression of Rattus norvegicus mtDNA in Mus musculus Cells Results in Multiple Respiratory Chain Defects*

Matthew McKenzieDagger and Ian Trounce§

From the Mutation Research Centre and the University of Melbourne, Department of Medicine, St. Vincent's Hospital, 41 Victoria Parade, Fitzroy 3065 Melbourne, Australia

Received for publication, May 12, 2000, and in revised form, July 19, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The production of in vitro and in vivo models of mitochondrial DNA (mtDNA) defects is currently limited by a lack of characterized mouse cell mtDNA mutants that may be expected to model human mitochondrial diseases. Here we describe the creation of transmitochondrial mouse (Mus musculus) cells repopulated with mtDNA from different murid species (xenomitochondrial cybrids). The closely related Mus spretus mtDNA is readily maintained when introduced into M. musculus mtDNA-less (rho 0) cells, and the resulting cybrids have normal oxidative phosphorylation (OXPHOS). When the more distantly related Rattus norvegicus mtDNA is transferred to the mouse nuclear background the mtDNA is replicated, transcribed, and translated efficiently. However, function of several OXPHOS complexes that depend on the coordinated assembly of nuclear and mtDNA-encoded proteins is impaired. Complex I activity in the Rattus xenocybrid was 46% of the control mean; complex III was 37%, and complex IV was 78%. These defects combined to restrict maximal respiration to 12-31% of the control and M. spretus xenocybrids, as measured polarographically using isolated cybrid mitochondria. These defects are distinct to those previously reported for human/primate xenocybrids. It should be possible to produce other mouse xenocybrid constructs with less severe OXPHOS phenotypes, to model human mtDNA diseases.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mitochondrial DNA (mtDNA)1 is a 16.5-kilobase pair genome unique to mitochondria, which encodes 13 essential protein subunits of the multimeric OXPHOS complexes I, III, IV, and V. Complex II is entirely nuclear gene-encoded. Unlike nuclear genes the mtDNA exists in thousands of copies per cell, is replicated throughout life, and in most animals including humans is maternally inherited. Transcription of mtDNA is linked to replication, and the 13 proteins are translated on mitochondrial ribosomes and assembled with around 60 nuclear gene products to produce the functional holocomplexes (for recent reviews see Refs. 1 and 2).

The five OXPHOS complexes act as a redox pathway, transferring electrons from NADH and FADH2 to molecular oxygen. The passage of electrons is linked to proton efflux from the matrix through complexes I, III, and IV across the mitochondrial inner membrane. The proton gradient in turn is the source of power for the H+-ATP synthase (2). OXPHOS produces the majority of the ATP of the cell and is also a major source of reactive oxygen species production. In efficiently respiring mitochondria around 2% of oxygen consumed is directly converted into reactive oxygen species, and this amount is increased when the respiratory chain is inhibited in in vitro and in vivo studies (3).

Genetic defects of OXPHOS may therefore result from nuclear or mtDNA gene mutations. Since the first descriptions of disease-related mtDNA mutations appeared just over 10 years ago (4, 5), the catalogue of such mutations has grown to over 50 (see Refs. 6 and 7 and MITOMAP). Clincal presentations of mtDNA diseases are extremely variable, although a few syndromes are associated with specific mtDNA defects. Presentations range from severe and progressive neonatal or childhood neuromuscular disease, to milder adult disease including muscle weakness, cardiac disease, diabetes, vision, and hearing loss (see Refs. 6-8).

Despite these genetic advances, our understanding of pathogenesis in mitochondrial diseases remains poor, with little progress made on the underlying causes of clinical heterogeneity and progression of symptoms, which in turn has inhibited development of directed therapies. The creation of in vitro and in vivo mouse models of mtDNA diseases is therefore of great current interest. However the unique features of mitochondrial genetics including the high cellular mtDNA copy number and the lack of demonstrated mechanisms of recombination have presented technical barriers to producing mtDNA "knockout" mice.

Several groups have reported different approaches aimed at directly manipulating the mitochondrial genotype of oocytes or zygotes or using direct mitochondrial injection into oocytes (see Ref. 9). Two other groups (10, 11) have reported production of transmitochondrial mice using an embryonic stem (ES) cell approach and one of very few characterized cultured mouse cell mtDNA mutants (a rRNA mutation resulting in resistance to chloramphenicol). One of these groups recently reported successful germ line transmission of this mtDNA mutation, although from limited data presented to date the phenotype appears to be post-natal lethal (12).

If the ES cell approach to producing transmitochondrial mice is validated, the major limitation to producing models is now the lack of available mtDNA mutants in cultured mouse cells. Another approach to producing OXPHOS defects in mouse cells was suggested by Kenyon and Moraes (13) who established that human mtDNA-less (rho 0) cells could be repopulated with closely related primate mtDNAs. The resulting "xenomitochondrial cybrids" could replicate and transcribe the foreign mtDNAs and showed defective respiratory chain complex I with preserved function of the other complexes (14).

Here we report the introduction of mtDNAs from different murid species into mouse cells to produce mouse xenomitochondrial cybrids. We have introduced closely related (Mus spretus) and more distantly related (Rattus norvegicus) murid mtDNAs into a Mus musculus rho 0 cell line, which in the latter case results in multiple respiratory chain defects similar to some human mtDNA diseases.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Lines and Culture Conditions-- All cells were grown in RPMI 1640 medium (Life Technologies, Inc.) supplemented with 10% fetal bovine serum (Life Technologies, Inc.) at 37 °C and 5% CO2. Primary fibroblast lines were created from a 2-day-old laboratory mouse (M. musculus, CBA/C57Bl6 cross) and 5-week-old M. spretus (Spret/Ei, a gift from Dr. Simon Foote, Walter & Eliza Hall Institute). Skin from the belly of euthanized mice was washed with phosphate-buffered saline with 2× penicillin/streptomycin (Life Technologies, Inc.) and incubated with 0.25% trypsin (Life Technologies, Inc.) in RPMI medium for 4 h at 4 °C, incubated at 37 °C for 20 min, then passed through a tissue sieve using a glass pestle, and plated in complete medium in 75-cm2 tissue culture flasks (Nunc, Denmark). Media were replaced twice weekly, and after 2-3 weeks the primary cultures began to grow vigorously, and aliquots were viably frozen.

Two independent mouse rho 0 cell clones were used, designated LMEB3 and LMEB5. These were produced from the parental line LMTK- by exposure to ethidium bromide and are described in detail elsewhere (15). These mtDNA-less cells are auxotrophic for uridine and pyruvate (see Ref. 16), and the medium was supplemented with glucose to 4.5 mg/ml, uridine, 50 µg/ml, and pyruvate, 1 mM (RPMI/GUP medium).

The following cell lines were obtained from the ATCC: NRK52E (R. norvegicus kidney epithelial cells), RN1T (R. norvegicus mammary tumor line), Chinese hamster ovary cells (Cricetulus grigaeus), and Syrian hamster kidney cells (Mesocricetus aureus).

Production of Transmitochondrial Cybrids-- Cybrids were produced by enucleation of mitochondrial donor cells and fusion of the cytoplasts with mouse rho 0 cells followed by selection for respiratory-competent transformants as described in detail previously for human cells (17). Cells used as mitochondrial donors included the mouse primary fibroblast line, the M. spretus primary fibroblast line, the Rattus lines NRK52E and RN1T, and the hamster lines Chinese hamster ovary cells and Syrian hamster kidney. Briefly, 5 × 106 cells were enucleated by centrifugation at in an isopycnic Percoll (Amersham Pharmacia Biotech) gradient in the presence of 10 µg/ml cytochalasin B (Sigma). The cytoplast/karyoplast mixture was combined with 2 × 106 mouse rho 0 cells and then centrifuged at 20,000 × g for 10 min; the supernatant was aspirated and the pellet overlaid with polyethylene glycol (Sigma) for 1 min. The polyethylene glycol was then removed, and the cells were gently resuspended in complete medium and plated at 104 and 105 cells per 100-mm dish in RPMI-GUP medium. After 24 h the medium was replaced with select medium as follows: RPMI supplemented with 5% dialyzed fetal bovine serum (Life Technologies, Inc.) and 50 µg/ml bromodeoxyuridine (Sigma). In this medium lacking uridine and pyruvate the rho 0 cells cannot grow, and the bromodeoxyuridine kills surviving TK+ mitochondrial donor cells so that only LMTK- cybrids can survive. After 7-14 days cybrid clones were isolated using cloning cylinders, expanded, and viably frozen. Three independent clones were frozen from each successful fusion experiment, and cybrids were used in experiments from passage 5 through passage 10.

To confirm the nuclear origin of the cybrids, karyotyping of a control cybrid and a Rattus xenocybrid clone was performed. Cells were grown in RPMI/GUP medium in a 25-cm2 flask. Cells were treated with 50 ng/ml demecolcine (Sigma) for 5 h, harvested, resuspended in 10 ml of 75 mM KCl, and incubated at room temperature for 12 min. Cells were pelleted before being resuspended in 5 ml of fresh methanol/acetic acid (3:1). Cells were fixed overnight at 4 °C, pelleted, washed once in fixative, and then resuspended to give a pale milky solution. Cells were then dropped onto wet, acid-washed slides from a distance of 70 cm, allowed to dry, and stained with Giemsa (Sigma).

mtDNA Genotyping by DNA Sequencing-- A mtDNA D-loop fragment was generated by PCR from genomic DNA isolated from cybrid clones. Primers were chosen to enable amplification from both mouse (18) and R. norvegicus (19) mtDNA. The mouse amplicon was 461 base pairs in length, whereas the rat amplicon was 496 base pairs due to intervening sequence insertions compared with the mouse mtDNA (18, 19). The forward primer sequence was 5'-ctc aac ata gcc gtc aag gc-3' representing nucleotides 15934-15953 (18), and the reverse primer was 5'-acc aaa cct ttg tgt tta tgg g-3' representing nucleotides 59-80. PCR was performed using 1.0 unit of Taq polymerase (Life Technologies, Inc.), 20 ng of DNA, and 35 cycles of 94 °C for 30 s, 55 °C for 1 min, and 72 °C for 1 min.

Sequencing was performed using 60 ng of purified amplicon, with a Thermo Sequenase II dye terminator cycle sequencing kit (Amersham Pharmacia Biotech). Sequencing reactions were visualized on an ABI 377 automated sequencer.

Southern Blot Determination of mtDNA-- The mouse and rat D-loop PCR amplicons described above were used to probe mtDNA, whereas a PCR fragment of mouse 18 S rRNA gene was used as a nuclear probe. This PCR amplicon was 501 base pairs in length; the forward primer sequence was 5'-ctg tgg taa ttc tag agc taa tac atg ccg-3', representing positions 151-180 of the mouse 18 S rRNA gene (GenBankTM accession number X00686) The reverse primer sequence was 5'-tat acg cta ttg gag ctg gaa tta cc-3', representing nucleotides 626-651. Probes were labeled with [32P]dCTP using a RediPrime II random prime labeling kit (Amersham Pharmacia Biotech). For each lane of a 0.85% agarose gel, 5 µg of genomic DNA was loaded after restriction with SacI (Life Technologies, Inc.), which has a single restriction site in mouse and rat mtDNA. The transfer, probe annealing, and washing was done using standard conditions.

Mitochondrial Protein Translation-- Mitochondrial translation products were labeled with [35S]methionine as described previously (20). Approximately 105 cells in single wells of a 24-well tissue culture dish (Nunc) were washed with methionine-free RPMI before adding 0.5 ml of the same medium containing 0.1 mg/ml cycloheximide and incubating the cells at 37 °C, 5% CO2 for 15 min. After this preincubation 50 µCi of [35S]methionine (ICN) was added to each well, and the cells returned to the incubator for 2 h. Cold methionine (0.1 mM, Sigma) was then added, and the cells were incubated a further 30 min. Cells were immediately harvested, centrifuged, and frozen at -80 °C.

Cell pellets were prepared for electrophoresis by thawing and dilution in 50 mM Tris, pH 6.8, containing 0.1% SDS and 1 mM beta -mercaptoethanol. The cell lysates were sonicated with 3 pulses at setting 5 using a Tosco sonicator (MSE, Melbourne, Australia). Electrophoresis of labeled proteins was performed using 15% acrylamide (1:36 bisacrylamide) mini-gels (CBS Scientific, Del Mar, CA) with 10 µg of cellular protein per lane. Gels were electrophoresed at 100 V for 30 min, fixed in methanol/acetic acid, treated with "Amplify" (Amersham Pharmacia Biotech), and dried for autoradiography.

Lactate Measurement-- Lactate was measured in media using a commercial kit (Sigma). Cybrids were grown to confluence in 24-well culture dishes, and the media were replaced with 0.5 ml of fresh media after two rinses with 1 ml of media, and the cells were incubated for 10 h. Samples of media were removed at 2-h intervals and tested immediately for lactate concentration.

Mitochondrial Isolation and Polarographic Analysis-- Mitochondrial isolation and polarography using freshly isolated mitochondria was performed as described previously in detail for human cell mitochondria (17). Control and xenomitochondrial cybrids (xenocybrids) were grown in paired cultures so that a control was always processed alongside the experimental xenocybrid culture. Cultures were expanded to around 109 cells by seeding 2 × 107 cells into roller bottles (Corning) in 200 ml of complete medium, expanded after 4 or 5 days to 1000 ml, and then harvested after another 4 days.

Mitochondria were isolated by digitonin lysis and homogenization, followed by differential centrifugation (17). The mitochondria were resuspended to around 20 mg/ml protein in isolation buffer and used immediately for polarographic analysis. Protein was measured according to the Lowry method. Aliquots were also frozen at -80 °C for enzymological analysis.

Polarography was performed using an Instech (Plymouth Meeting, PA) microelectrode and chamber coupled with a magnetic stirrer and an Instech model 203 dual oxygen electrode amplifier with output to a chart recorder. Each mitochondrial isolate was tested for respiratory capacity using pyruvate plus malate, glutamate plus malate, and succinate as substrates. Two runs were performed with each substrate, and in each run two additions of ADP were made. Conditions and experimental details were as described previously (17).

OXPHOS Enzymology-- Complex I (NADH:ubiquinone oxidoreductase, EC 1.6.5.3), complex II (succinate:ubiquinone oxidoreductase, EC 1.3.5.1), complex II + III (succinate:cytochrome c oxidoreductase), and complex IV (ferrocytochrome-c:oxygen oxidoreductase, or cytochrome oxidase, EC 1.9.3.1) activities were measured spectrophotometrically, essentially as described previously (17), with the following modifications. A single beam spectrophotometer was used for all assays (Cintra 10, GBC Melbourne) instead of a dual-beam machine. For complex I, the oxidation of NADH was followed at 340 nm (21) using ubiquinone-1 (Sigma) as electron acceptor. For the complex II, II + III, and IV assays, conditions were as described previously (17) except the single-beam machine was used. For each assay, each mitochondrial sample was tested in triplicate.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Production of Transmitochondrial Cybrids-- Control cybrids produced by fusion of the rho 0 cell clone LMEB3 with enucleated M. musculus primary fibroblasts were obtained at a frequency of around one per 5 × 103 rho 0 cells used. Similar cybrid frequencies were obtained in a fusion of LMEB3 with enucleated M. spretus cells (diverged from M. musculus 2-3 million years ago, see Refs. 22-24, and see Fig. 1). Both the control cybrids and M. spretus xenomitochondrial cybrids were similar in appearance and growth characteristics to each other and to the parental LMTK- cell line. Fusions using enucleated Rattus NRK52E cells with LMEB5 and enucleated Rattus RN1T cells with LMEB3 also produced cybrids at high frequencies, around one per 104 rho 0 cells used. However both these sets of cybrid clones grew more slowly, showed a morphology intermediate between the control cybrids and the rho 0 cells, and acidified the media much more quickly than the control cybrids. The Mus/Rattus divergence is dated at around 10 million years ago (Fig. 1). Table I summarizes the amino acid sequence differences between the M. musculus and R. norvegicus mtDNA-encoded proteins.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   Brief phylogeny of the Muridae showing divergence times estimated from molecular studies (22-24). Divergence times are indicated by the scale below the phenogram, in millions of years before present (m.y.b.p.). Although M. spretus and R. norvegicus (subfamily Murinae) mtDNA could readily be maintained in M. musculus cells, Cricetulus and Mesocricetus (subfamily Cricetinae) mtDNA could not.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Comparison of M. musculus and R. norvegicus mitochondrial translation products

Fusions of enucleated hamster cells with LMEB3 failed to produce any cybrids in two experiments, one using Chinese hamster (C. grigaeus) cells and the other using Syrian golden hamster (M. aureus) cells. The Muridae subfamily Cricetinae, which includes the hamsters, diverged from the Murinae subfamily around 16 million years ago (Fig. 1).

Karyotyping of a control (M. musculus) cybrid and a Rattus xenocybrid revealed the same number of chromosomes, with a mean of 40 ± 2.2 (n = 4 counts) for the control, and 40 ± 1.5 (n = 6 counts) for the xenocybrid.

mtDNA Genotyping of Cybrids by DNA Sequencing-- For the M. spretus and R. xenocybrids, mitochondrial transfer was verified by direct sequencing of a PCR fragment of the mtDNA D-loop region. The M. spretus xenocybrid showed 81% identity with the published M. musculus sequence (18) for the region sequenced (GenBankTM accession number AF287305). The Rattus xenocybrids produced using NRK52E cells as mitochondrial donors showed only 62% identity to M. musculus for the region sequenced and in agreement with the published R. norvegicus sequence (19). The cybrids made from RN1T cells showed a single nucleotide difference to the R. norvegicus sequence, an insertion of a C in a 8-C tract at nucleotide pair 16075. This cell line is listed by ATCC as Rattus rattus, but this almost perfect identity with the R. norvegicus sequence indicates it is also derived from R. norvegicus, as R. rattus would be expected to show many more sequence differences in this highly polymorphic D-loop region, based on molecular studies of these two species (25).

Southern Blot Determination of mtDNA in the Rattus Xenocybrid-- Southern blot of control cybrid and Rattus xenocybrid DNA after restriction with SacI and probing with a mouse and rat mtDNA D-loop PCR amplicon showed similar mtDNA hybridization signals. SacI has a single restriction site in both mouse and rat mtDNA, resulting in a single band seen at 16.5 kilobase pairs. The blot showed that similar levels of mtDNA are maintained in the xenocybrid compared with the control.

Mitochondrial Protein Translation in the Rattus Xenocybrid-- Mitochondrial translation products labeled in the presence of cycloheximide are shown after electrophoresis in Fig. 2. Most of the 13 proteins are identifiable by mobility together with characteristic intensity of labeling, as shown at left in Fig. 2. The profiles of the control cybrid and Rattus xenocybrid are similar overall. One mobility polymorphism between the M. musculus and Rattus products is evident, possibly the ND2 gene product NAD2, which was also seen in the parental NRK52E cells (not shown). Two proteins appear to be produced in increased amounts, possibly NAD4 and ATP6, while two others, likely NAD5 and cytochrome b, appear to be decreased. The same pattern was observed in two independent labeling experiments. The similarity of the profiles shows that transcription and translation of the foreign mtDNA is not markedly impaired.


View larger version (86K):
[in this window]
[in a new window]
 
Fig. 2.   Mitochondrial protein translation. C, M. musculus control cybrid; X, R. norvegicus xenocybrid. Mitochondrial translation products are identified at left (ND, NADH dehydrogenase subunits; CO, cytochrome oxidase subunits; ATP, ATP synthase subunits; Cytb, apocytochrome b). All mitochondrial proteins appear to be produced in the xenocybrid, although ratios of some appear to differ in this long pulse (2 h) labeling experiment, as indicated by the arrows. The asterisk indicates a mitochondrial translation product showing a mobility polymorphism, probably ND2. For each lane, 10 µg of cellular protein was loaded, and the 15% polyacrylamide mini-gel was electrophoresed under reducing conditions. CAP indicates the labeling of control cybrid cells in the presence of chloramphenicol in addition to cycloheximide.

Lactate Measurement-- Fig. 3 shows the lactate production from the control and M. spretus cybrids, the Rattus cybrid, and the rho 0 cell line. A respiratory defect is signaled in the Rattus xenocybrid by the 10-fold greater lactate production compared with the control cybrid, whereas the M. spretus xenocybrid shows similar low lactate production to the control (Fig. 3). The rho 0 cell line produced 2-fold greater amounts of lactate than the Rattus xenocybrid, indicating that the cybrid was able to produce some ATP oxidatively.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 3.   Lactate production in xenocybrids and rho 0 cells. A severe OXPHOS defect is signaled in the Rattus xenocybrid (black-square) by a 10-fold increased lactate production compared with the control and M. spretus cybrids (). The LMEB3 rho 0 cell line (black-triangle), without oxidative ATP production, shows a further 2-fold increase, showing that the Rattus xenocybrid is producing some ATP aerobically.

Polarographic Measurement of OXPHOS in Xenocybrids-- Fig. 4 shows typical polarograph traces of site I (glutamate + malate) and site II (succinate) oxidation in the control and Rattus xenocybrid mitochondria. The control traces (A and B) show good coupling to ADP stimulation and high respiration rates and ADP/O ratios. In the Rattus xenocybrid (C and D), site I-linked respiration is impaired but remains coupled to ADP availability, whereas site II-linked respiration shows a more severe defect, with little stimulation by added ADP. Comparison of the mean specific respiratory rates from three independent experiments (Table II) revealed that the M. spretus cybrid showed similar respiratory capacity to the control, whereas the Rattus cybrid state III (ADP-stimulated) rates were significantly lower than the control. This was true for site I substrates (31% mean control rates) and succinate (12% mean control rate). The ADP/O ratios obtained with site I substrates were also significantly lower in the Rattus cybrid (71% controls, Table II). These results are consistent with defects in either or both complex III or IV limiting respiratory chain electron flow, possibly combined with a complex I defect.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 4.   Polarographic analysis of OXPHOS using freshly isolated cybrid mitochondria. The control cybrid mitochondria (traces A and B) show a normal well coupled profile of ADP-stimulated OXPHOS. The Rattus xenocybrid (traces C and D) shows a greatly reduced rate of oxygen consumption with glutamate + malate, even lower with succinate, and a lowered ADP/O ratio with glutamate + malate. The ADP/O ratio was not measurable with succinate in the Rattus xenocybrid due to the state III rate deteriorating before all the added ADP was phosphorylated. The numbers to the left of each trace show the state III (ADP-stimulated) respiration rates as ng of atom O reduced per min per mg of mitochondrial protein, and the numbers to the right of the traces show ADP/O ratios. Substrates used were: g+m, glutamate + malate; succ., succinate.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Polarographic analysis of OXPHOS in mitochondria isolated from xenocybrids
Numbers are mean ± S.D. of three mitochondrial isolates studied. RCR (respiratory control ratio) is the ratio of state III to subsequent state IV respiration. ADP/O ratio indicates the number of ADP molecules phosphorylated per oxygen atom used.

OXPHOS Enzymology-- Table III summarizes the mean activity of OXPHOS complexes I, II, II + III, and IV measured in triplicate using three independent mitochondrial isolates from each of the control, M. spretus and Rattus xenocybrids. No significant differences were found for the M. spretus xenocybrid compared with the control. The Rattus xenocybrid showed normal complex II activity with varying defects of the other complexes. Complex I (rotenone-sensitive activity) was significantly decreased to 46% of the control levels, whereas complex IV showed a partial but significant defect with 78% control activity (Table III). The most striking defect was indicated by the II + III assay result, showing only 37% of the control activity (Table III). Together with the preserved complex II activity, this result suggests a severe complex III defect since this linked assay is normally rate-limited by complex II (26).

                              
View this table:
[in this window]
[in a new window]
 
Table III
Activities of OXPHOS enzyme complexes in mitochondria from xenocybrids
Numbers are mean ± S.D., N = 3 mitochondrial isolates.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

By introducing R. norvegicus mtDNA into a mouse mtDNA-less cell line, we have produced a new mouse in vitro model of a severe mtDNA OXPHOS defect. Only a handful of mtDNA mouse cell mutants have been described, the best characterized being a point mutation in the 16 S rRNA gene resulting in resistance of the mitochondrial ribosome to chloramphenicol (CAPR) (27) which results in multiple respiratory chain defects (10, 28).

The lack of methods to produce targeted mtDNA knockouts has limited attempts to produce mtDNA mutant mice. A transfection approach using a DNA construct linked to a mitochondrial target peptide leader sequence is promising but has not yet succeeded in transforming mitochondria in cultured cells (29, 30). Kenyon and Moraes (13) pioneered the approach of xenomitochondrial cybrids by showing that only the most closely related primate mtDNAs could be maintained in human rho 0 cells. These human/primate xenomitochondrial cybrids exhibited defects in respiratory chain complex I (14) and an increased sensitivity to programmed cell death when treated with complex I inhibitors (31).

The finding by Moraes et al. (32) that human cells preferentially replicate even defective human mtDNA over introduced normal primate mtDNAs showed that mtDNA determinants for trans-acting factors may be more important than OXPHOS functionality.

In the present studies we found that there is also a limit on mtDNA compatibility as indicated by the inability of the mouse rho 0 cells to maintain hamster mtDNA. Divergence of hamsters (Muridae subfamily Cicetidae) from the Murinae subfamily including mice and rats was around 16 million years ago (Fig. 1 (22)). The Mus/Rattus divergence was around 10 million years ago (Fig. 1 (23)) and may approximate the limit of compatibility in this system. The resulting xenocybrids exhibited a severe OXPHOS impairment (Table II and III and Figs. 3 and 4) despite showing preserved mtDNA replication and translation (Fig. 3). This shows the defects are consequent to the mismatches between the mouse nuclear OXPHOS subunits and the Rattus mtDNA subunits (Table I; see also accompanying article (33)). A marked defect of complex I was seen in the Rattus xenocybrids (Table III) but unlike the human/primate xenocybrids there was also a striking defect of complex III together with a partial defect of complex IV (Table III). This shows that predictions from the human/primate system do not translate directly into the murid system.

The number of amino acid substitutions range from only 3 in the highly conserved COX-2 protein, to 133 in NAD5 (Table I), making it difficult to predict which changes are functionally important. The suggestion of a severe complex III defect is particularly interesting since cytochrome b is the only mtDNA-encoded subunit of this complex. Cytochrome b shows 26 amino acid differences between M. musculus and R. norvegicus (Table I). The polarographic results (Table II and Fig. 4) show that succinate-linked respiration is more severely impaired than site 1-linked respiration, despite the latter requiring the same electron transfer pathway through complexes III and IV. This could result from substrate inhibition exacerbating the complex III defect, as there will be a greater steady state ubiquinol concentration during succinate oxidation compared with site 1-linked substrate oxidation due to the higher specific activity of complex II over complex I.

M. spretus and M. musculus diverged approximately 2-3 million years ago (Fig. 1). Although the present studies show no differences in OXPHOS capacity for the M. spretus xenocybrids, further studies may show subtle but important defects in this model. The levels of M. spretus mtDNA were too low in the mice produced by Irwin et al. (9) to conclude there were no pathogenic effects, and creation of this mouse would be an important proof of the principle from which to proceed to make other xenomitochondrial mice using the ES cell approach.

By making further xenomitochondrial constructs with species intermediate between M. spretus and Rattus, it should be possible to produce cybrids with intermediate OXPHOS phenotypes. By comparative studies of OXPHOS and mtDNA sequences from the species used, it should be possible to gain important new insights into the nuclear-mtDNA-encoded subunit interactions, in addition to the potential value of this system in producing mouse models of human mtDNA diseases. Evolution has provided a rich source of options. The Muridae is the most successful family of the order Rodentia, having the greatest number of extant species of any mammalian family (22, 24). There are literally dozens of potential constructs that can be produced. The Gerbillinae subfamily of Muridae, the gerbils, are intermediate in divergence to Rattus and the hamsters (Fig. 1) and may produce viable xenocybrids. We would predict these constructs to produce severe OXPHOS defects if the mtDNAs could be replicated.

    ACKNOWLEDGEMENTS

We thank Dr. Simon Foote for the M. spretus specimen. We also thank Professor Richard Cotton, Professor Ed Byrne, and Dr. Andrew Wilks for support.

    FOOTNOTES

* This work was supported by National Health and Medical Research Council of Australia Grant 970543 (to I. T), grants-in-aid from the Ramaciotti Foundation, ANZ trustees, and the Percy Baxter trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a University of Melbourne postgraduate scholarship.

§ To whom correspondence should be addressed. Tel.: 61-3-9288-2977; Fax: 61-3-9288-2989; E-mail: trouncia@svhm.org.au.

Published, JBC Papers in Press, July 24, 2000, DOI 10.1074/jbc.M004070200

    ABBREVIATIONS

The abbreviations used are: mtDNA, mitochondrial DNA; OXPHOS, oxidative phosphorylation; ES cells, embryonic stem cells; PCR, polymerase chain reaction.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Clayton, D. A. (2000) Exp. Cell Res. 255, 4-9
2. Saraste, M. (1999) Science 283, 1488-1492
3. Kwong, L. K., and Sohal, R. S. (1998) Arch. Biochem. Biophys. 350, 118-126
4. Wallace, D. C., Singh, G., Lott, M. T., Hodge, J. A., Schurr, T. G., Lezza, A. M. S., Elsas, L. J., II, and Nikoskelainen, E. K. (1988) Science 242, 1427-1430
5. Holt, I. J., Harding, A. E., and Morgan-Hughes, J. A. (1988) Nature 331, 717-719
6. Wallace, D. C. (1999) Science 283, 1482-1487
7. Graff, C., Clayton, D. A., and Larsson, N-G. (1999) J. Int. Med. 246, 11-23
8. Lightowlers, R. N., Chinnery, P. F., Turnbull, D. M., and Howell, N. (1997) Trends Genet. 13, 450-455
9. Irwin, M. H., Johnson, L. W., and Pinkert, C. A. (1999) Transgenic Res. 8, 119-123
10. Levy, S. E., Waymire, K. G., Kim, Y. L., MacGregor, G. R., and Wallace, D. C. (1999) Transgenic Res. 8, 137-145
11. Marchington, D. R., Barlow, D., and Poulton, J. (1999) Nat. Med. 5, 957-960
12. Wallace, D. C., Levy, S. E., and Sligh, J. E. (1999) Am. J. Hum. Genet. 65, 18 (abstr.)
13. Kenyon, L., and Moraes, C. T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 9131-9135
14. Barrientos, A., Kenyon, L., and Moraes, C. T. (1998) J. Biol. Chem. 273, 14210-14217
15. Trounce, I. A., Schmiedel, J., Hsiu-Chuan, Y., Hossini, S., Brown, M. D., Olsen, G., and Wallace, D. C. (2000) Nucleic Acids Res. 28, 2164-2170
16. King, M. P., and Attardi, G. (1996) Methods Enzymol. 264, 313-334
17. Trounce, I. A., Kim, Y. L., Jun, A. S., and Wallace, D. C. (1996) Methods Enzymol. 264, 484-509
18. Bibb, M. J., Van Etten, R. A., Wright, C. T., Walberg, M. W., and Clayton, D. A. (1981) Cell 26, 167-180
19. Gadaleta, G., Pepe, G., De Candia, G., Quagliariello, C., Sbisa, E., and Saccone, C. (1989) J. Mol. Evol. 28, 497-516
20. Brown, M. D., Yang, C.-C., Trounce, I., Torroni, A., Lott, M. T., and Wallace, D. C. (1992) Am. J. Hum. Genet. 51, 378-385
21. Estornell, E., Fato, R., Pallotti, F., and Lenaz, P. (1993) FEBS Lett. 332, 127-131
22. Catzeflis, F. M., Dickerman, A. W., Michaux, J., and Kirsch, J. A. W. (1993) in Mammal Phylogeny: Placentals (Szalay, F. S. , Novacek, M. J. , and McKenna, M. C., eds) , pp. 159-172, Springer-Verlag Inc., New York
23. Bonhomme, F., and Guenet, J.-L. (1996) in Genetic Variants and Strains of the Laboratory Mouse (Lyon, M. F. , Rastan, S. , and Brown, S. D. M., eds) , pp. 1577-1595, Oxford University Press, Oxford
24. Silver, L. M. (1995) Mouse Genetics , Oxford University Press, New York
25. Verneau, O., Caatzeflis, F., and Furano, A. V. (1997) J. Mol. Evol. 45, 424-436
26. Taylor, R. W., Birch-Machin, M. A., Bartlett, K., and Turnbull, D. M. (1993) Biochim. Biophys. Acta 1181, 261-265
27. Blanc, H., Wright, C. T., Bibb, M. J., Wallace, D. C., and Clayton, D. A. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 3789-3793
28. Howell, N., and Nalty, M. S. (1988) Somatic Cell Mol. Genet. 14, 185-193
29. Seibel, P., Trappe, J., Villani, G., Klopstock, T., Papa, S., and Reichmann, H. (1995) Nucleic Acids Res. 23, 10-17
30. Seibel, M., Bachmann, C., Schmiedel, J., Wilken, N., Wilde, F., Reichmann, H., Isaya, G., and Seibel, P. (1999) Biol. Chem. 380, 961-967
31. Barrientos, A., and Moraes, C. T. (1999) J. Biol. Chem. 274, 16188-16197
32. Moraes, C. T., Kenyon, L., and Hao, H. (1999) Mol. Biol. Cell 10, 3345-3356
33. Dey, R., Barrientos, A., and Moraes, C. T. (2000) J. Biol. Chem. 275, 31520-31527


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GeneticsHome page
A. Burzynski, M. Zbawicka, D. O. F. Skibinski, and R. Wenne
Doubly Uniparental Inheritance Is Associated With High Polymorphism for Rearranged and Recombinant Control Region Haplotypes in Baltic Mytilus trossulus
Genetics, November 1, 2006; 174(3): 1081 - 1094.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
E.C. Spikings, J. Alderson, and J.C.St. John
Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer
Hum. Reprod. Update, July 1, 2006; 12(4): 401 - 415.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Kasahara, K. Ishikawa, M. Yamaoka, M. Ito, N. Watanabe, M. Akimoto, A. Sato, K. Nakada, H. Endo, Y. Suda, et al.
Generation of trans-mitochondrial mice carrying homoplasmic mtDNAs with a missense mutation in a structural gene using ES cells
Hum. Mol. Genet., March 15, 2006; 15(6): 871 - 881.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. H El Shourbagy, E. C Spikings, M. Freitas, and J. C St John
Mitochondria directly influence fertilisation outcome in the pig
Reproduction, February 1, 2006; 131(2): 233 - 245.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
M. P. Bayona-Bafaluy, S. Muller, and C. T. Moraes
Fast Adaptive Coevolution of Nuclear and Mitochondrial Subunits of ATP Synthetase in Orangutan
Mol. Biol. Evol., March 1, 2005; 22(3): 716 - 724.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
J. C St John, R. E I Lloyd, E. J Bowles, E. C Thomas, and S. El Shourbagy
The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective
Reproduction, June 1, 2004; 127(6): 631 - 641.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. C. St. John and G. Schatten
Paternal Mitochondrial DNA Transmission During Nonhuman Primate Nuclear Transfer
Genetics, June 1, 2004; 167(2): 897 - 905.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. McKenzie, I. A. Trounce, C. A. Cassar, and C. A. Pinkert
Production of homoplasmic xenomitochondrial mice
PNAS, February 10, 2004; 101(6): 1685 - 1690.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
M. McKenzie, M. Chiotis, C. A. Pinkert, and I. A. Trounce
Functional Respiratory Chain Analyses in Murid Xenomitochondrial Cybrids Expose Coevolutionary Constraints of Cytochrome b and Nuclear Subunits of Complex III
Mol. Biol. Evol., July 1, 2003; 20(7): 1117 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
B. J. Battersby and E. A. Shoubridge
Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to differences in respiratory chain function or efficiency of replication
Hum. Mol. Genet., October 1, 2001; 10(22): 2469 - 2479.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/40/31514    most recent
M004070200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar